Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension
Clinical trial NCT00529750 · COMPLETED
Trial details
- NCT number
- NCT00529750
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2005-01-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.